On July 3, 2025, Citigroup analyst Christopher Allen reaffirmed a neutral rating on CME Group (CME, Financial). Despite maintaining this rating, Allen made a notable adjustment to the stock's price target.
The updated price target for CME Group (CME, Financial) has been raised from $265.00 to $275.00 USD, marking a 3.77% increase from the previous target.
Investors should take note that while the rating remains neutral, the raised price target suggests a positive shift in the stock's projected value. The adjustments reflect Citigroup's updated outlook on CME Group’s (CME, Financial) performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 15 analysts, the average target price for CME Group Inc (CME, Financial) is $279.27 with a high estimate of $306.00 and a low estimate of $225.00. The average target implies an upside of 1.30% from the current price of $275.69. More detailed estimate data can be found on the CME Group Inc (CME) Forecast page.
Based on the consensus recommendation from 18 brokerage firms, CME Group Inc's (CME, Financial) average brokerage recommendation is currently 2.6, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for CME Group Inc (CME, Financial) in one year is $258.64, suggesting a downside of 6.18% from the current price of $275.69. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the CME Group Inc (CME) Summary page.
